Since taking over as FDA commissioner in May, Scott Gottlieb has moved forward at a ferocious pace in rolling out new major initiatives and advancing policy developments that will have significant impacts on product-makers and patients alike.
Gottlieb spoke Nov. 3 before National Press Club in Washington, D.C. (Also see "Five Takeaways From Commissioner Gottlieb's Talk At The National Press Club" - Medtech Insight, 7 November,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?